Table of Contents
Sales of sleep aids maintained strong growth in 2016, rising by 10% in value terms, due to many new product launches in 2016. The regulatory status of melatonin in Finland changed following a decision by The Finnish Medicine Agency (Fimea) in November 2013, stating that products containing 0.5-1mg of melatonin can be sold as dietary supplements and marketed with the European Commission approved health claims. The significance of the decision is that dietary supplements can be sold in channels ou...
Euromonitor International’s Sleep Aids in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...
The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...
The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...